PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 630-634

  Christopherson, Cindy ^a   Kidane, Yorda ^a   Conway, Brian ^b,c   Krowka, John ^d   Sheppard, Haynes ^d   Kwok, Shirley ^a  

^a ROCHE MOLECULAR SYSTEMS   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Viridae Clinical Sciences   (Canada)

^d VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; NEVIRAPINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SURVIVAL TIME; VIREMIA;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033980093     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.630-634.2000     Document Type: Article

References (24)

1. Betts, M., J. Krowka, T. Kepler, M. Davidian, C. Christopherson, S. Kwok, L. Louie, J. Eron, H. Sheppard, and J. Frelinger. 1999. Human immunodeficiency virus type-1 (HIV-1) specific cytotoxic T lymphocyte activity is inversely correlated with HIV-1 viral load in HIV-1 infected long-term survivors. AIDS Res. Hum. Retrovir. 15:1219-1228.
2. Bieniasz, P. D., K. Ariyoshi, M. A. Bourelly, S. Bloor, R. B. Foxall, E. C. Harwood, and J. N. Weber. 1993. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV-1-infected individuals. AIDS 7:803-806.
3. Bruisten, S. M., P. H. J. Frissen, P. Van Swieten, P. R. Harrigan, I. Kinghorn, B. Larder, H. M. Weigel, E. De Vries, R. M. Regez, J. H. Henrichs, M. Koot, and J. G. Huisman. 1997. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons. AIDS Res. Hum. Retrovir. 13:327-335.
4. Bruisten, S. M., P. Reiss, A. E. Loeliger, P. Van Swieten, R. Schuurman, C. Boucher, G. Weverling, and J. G. Huisman. 1998. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons. AIDS Res. Hum. Retrovir. 14:1053-1058.
5. Brun-Vezinet, F., C. Boucher, C. Loveday, D. Descamps, V. Fauveau, J. Izopet, D. Jeffries, S. Kaye, C. Krzyanowski, A. Nunn, R. Schuurman, J. M. Seigneurin, C. Tamalet, R. Tedder, J. Weber, and G. J. Weverling. 1997. HIV-1 viral load, phenotvpe, and resistance in a subset of drug-naive participants from the Delta trial. Lancet 350:983-990.
6. Donovan, R. M., R. E. Dickover, E. Goldstein, R. G. Huth, and J. R. Carlson. 1991. HIV-1 proviral copy number in blood mononuclear cells from AIDS patients on zidovudine therapy. J. Acquir. Immune Defic. Syndr. 8:766-769.
7. Finzi, D., J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, and R. F. Siliciano. 1999. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
8. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
9. Folks, T. M., D. Powell, M. Lightfoote, S. Koenig, A. S. Fauci, S. Benn, A. Rabson, D. Daugherty, H. E. Gendelman, M. D. Hoggan, S. Venkatesan, and M. A. Martin. 1986. Biological and biochemical characterization of cloned LEU-3 cells surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 164:280-290.
10. Gupta, P., M. Ding, M. Cottrill, C. Rinaldo, L. Kingsley, S. Wolinsky, and J. Mellors. 1995. Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay. J. Clin. Microbiol. 33: 1670-1673.
11. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
12. Jurriaans, S., B. Van Gemen, G. J. Weverling, D. Van Strijp, P. Nara, R. Coutinho, M. Koot, H. Schuitemaker, and J. Goudsmit. 1994. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 204:223-233.
13. Katzenstein, D., S. Hammer, M. Hughes, H. Gundacker, J. B. Jackson, S. Fiscus, S. Rasheed, T. Elbeik, R. Reichman, A. Japour, T. Merigan, and M. Hirsch. 1996. The relation of virological and immunological markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N. Engl. J. Med. 335:1091-1098.
14. Longo, M. C., M. S. Berninger, and J. L. Hartley. 1990. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93:125-128.
15. Mellors, J. W., A. Munoz, J. V. Giorgi, J. B. Margolick, C. J. Tassoni, P. Gupta, L. A. Kingsley, J. A. Todd, A. J. Saah, R. Detels, J. P. Phair, and C. R. Rinaldo. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
16. Meyers, T. W., and D. H. Gelfand. 1991. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 30: 7661-7666.
17. Michael, N. L., S. A. Herman, S. Kwok, K. Dreyer, J. Wang, C. Christopherson, J. P. Spadoro, K. K. Young, V. Polonis, F. E. McCutchan, J. Carr, J. R. Mascola, L. L. Jagodzinski, and M. L. Robb. 1999. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 37: 2557-2563.
18. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
19. Mulder, J., R. Resnick, B. Saget, S. Scheibel, S. Herman, H. Payne, R. Harrigan, and S. Kwok. 1997. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J. Clin. Microbiol. 35:1278-1280.
20. O'Brien, W., P. Hartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, M. Simberkoff, and J. Hamilton. 1996. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
21. Perelson, A. S., P. Essunger, Y. Cao, M. Vesenen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387:188-191.
22. Sheppard, H. W., W. Lang, M. S. Ascher, E. Vittinghoff, and W. Winkelstein. 1993. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 7:1159-1166.
23. Triques, K., J. Coste, J. L. Perret, C. Segarra, E. Mpoudi, J. Reynes, E. Delaporte, A. Butcher, K. Dreyer, S. Herman, J. Spadoro, and M. Peeters. 1999. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 37:110-116.
24. Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1294.